aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
3.240
-0.040 (-1.22%)
Oct 24, 2024, 4:00 PM EDT - Market closed
aTyr Pharma Market Cap
aTyr Pharma has a market cap or net worth of $245.58 million as of October 24, 2024. Its market cap has increased by 204.31% in one year.
Market Cap
245.58M
Enterprise Value
183.80M
1-Year Change
204.31%
Ranking
Category
Stock Price
Market Cap Chart
Since May 7, 2015, aTyr Pharma's market cap has decreased from $337.10M to $245.58M, a decrease of -27.15%. That is a compound annual growth rate of -3.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2024 | 248.60M | 200.97% |
| Dec 29, 2023 | 82.60M | 30.08% |
| Dec 30, 2022 | 63.50M | -69.41% |
| Dec 31, 2021 | 207.60M | 428.24% |
| Dec 31, 2020 | 39.30M | 142.59% |
| Dec 31, 2019 | 16.20M | 8.72% |
| Dec 31, 2018 | 14.90M | -85.70% |
| Dec 29, 2017 | 104.20M | 104.31% |
| Dec 30, 2016 | 51.00M | -78.06% |
| Dec 31, 2015 | 232.50M | -31.03% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nektar Therapeutics | 259.55M |
| Accolade | 257.72M |
| Rigel Pharmaceuticals | 256.71M |
| Mersana Therapeutics | 252.71M |
| Acrivon Therapeutics | 249.64M |
| MacroGenics | 247.13M |
| Compass Therapeutics | 246.28M |
| Poseida Therapeutics | 242.80M |